Showing results (41-50 of 53) with videos related to
Sort By:
Pageof 6
Cancer Research|September 20, 2022
Stress-Mediated Attenuation of Translation Undermines T-cell Activity in CancerBrian P Riesenberg, Elizabeth G Hunt, Megan D Tennant, et al.JCO Oncology Practice|August 28, 2020
Barriers to the Delivery of Timely, Guideline-Adherent Adjuvant Therapy Among Patients With Head and Neck CancerEvan M Graboyes, Chanita Hughes Halbert, Hong Li, et al.Journal for Immunotherapy of Cancer|January 12, 2022
B cells imprint adoptively transferred CD8<sup>+</sup> T cells with enhanced tumor immunityAubrey S Smith, Hannah M Knochelmann, Megan M Wyatt, et al.Oncoimmunology|August 19, 2021
Modeling <i>ex vivo</i> tumor-infiltrating lymphocyte expansion from established solid malignanciesHannah M Knochelmann, Amalia M Rivera-Reyes, Megan M Wyatt, et al.JCO Oncology Practice|March 10, 2021
Development and Evaluation of a Navigation-Based, Multilevel Intervention to Improve the Delivery of Timely, Guideline-Adherent Adjuvant Therapy for Patients With Head and Neck CancerEvan M Graboyes, Katherine R Sterba, Hong Li, et al.Molecular Cancer Therapeutics|December 16, 2014
Wee-1 kinase inhibition overcomes cisplatin resistance associated with high-risk TP53 mutations in head and neck cancer through mitotic arrest followed by senescenceAbdullah A Osman, Marcus M Monroe, Marcus V Ortega Alves, et al.Oral Oncology|September 26, 2022
Outcomes for recurrent oral cavity squamous cell carcinomaKevin J Contrera, Mark E Zafereo, Dan Yaniv, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2014
Squamous cell carcinoma of the oral tongue in young non-smokers is genomically similar to tumors in older smokersCurtis R Pickering, Jiexin Zhang, David M Neskey, et al.Cell Reports. Medicine|November 10, 2021
Response and recurrence correlates in individuals treated with neoadjuvant anti-PD-1 therapy for resectable oral cavity squamous cell carcinomaSixue Liu, Hannah M Knochelmann, Shirley H Lomeli, et al.Cancer Research|February 19, 2015
Evolutionary Action Score of TP53 Coding Variants Is Predictive of Platinum Response in Head and Neck Cancer PatientsAbdullah A Osman, David M Neskey, Panagiotis Katsonis, et al.Pageof 6